Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn F Larson

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month ExperienceMichael J Joyner, Jonathon W Senefeld, Stephen A Klassen, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasmaJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
The New England Journal of Medicine|February 1, 2021
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19Michael J Joyner, Rickey E Carter, Jonathon W Senefeld, et al.
Mayo Clinic Proceedings|August 31, 2020
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized PatientsMichael J Joyner, Katelyn A Bruno, Stephen A Klassen, et al.
Nature Communications|August 12, 2021
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donorsKatie L Kunze, Patrick W Johnson, Noud van Helmond, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 20, 2023
Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-AnalysisJonathon W Senefeld, Ellen K Gorman, Patrick W Johnson, et al.
Plos Medicine|December 20, 2021
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry studyJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month ExperienceMichael J Joyner, Jonathon W Senefeld, Stephen A Klassen, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasmaJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
The New England Journal of Medicine|February 1, 2021
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19Michael J Joyner, Rickey E Carter, Jonathon W Senefeld, et al.
Mayo Clinic Proceedings|August 31, 2020
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized PatientsMichael J Joyner, Katelyn A Bruno, Stephen A Klassen, et al.
Nature Communications|August 12, 2021
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donorsKatie L Kunze, Patrick W Johnson, Noud van Helmond, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 20, 2023
Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-AnalysisJonathon W Senefeld, Ellen K Gorman, Patrick W Johnson, et al.
Plos Medicine|December 20, 2021
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry studyJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
Pageof 3